Recruiting studies: Pulmonary Hypertension Due To Lung Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Bioenergetic Effect of Pioglitazone in CLD-PH
Phase 2 · 1 location(s) · Emory University · NCT06336798 Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Phase 2 · 16 location(s) · Tectonic Operating Company, Inc. · NCT07473700 A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Phase 3 · 16 location(s) · Liquidia Technologies, Inc. · NCT07285655 Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
Phase N/A · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT07537517 Giessen Pulmonary Hypertension in Lung Cancer Registry
Phase N/A · 1 location(s) · University of Giessen · NCT04467333 Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)
Phase 4 · 1 location(s) · University of California, Davis · NCT07322133 Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients
Phase N/A · 1 location(s) · Medical University of Graz · NCT07498244 Pulmonary Hypertension Biorepository and Registry
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT04808596 Ventilator Pressure and Optimization of Compliance and Hemodynamics
NA · 1 location(s) · University of Alabama at Birmingham · NCT06512935 DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease
Phase N/A · 67 location(s) · United Therapeutics · NCT06388421 A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety
NA · 3 location(s) · Pulnovo Medical, Inc. · NCT07214376 Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension
Phase 4 · 1 location(s) · Zagazig University · NCT04484675 Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
Phase N/A · 1 location(s) · Johns Hopkins University · NCT06299436 LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Phase 2 · 3 location(s) · OrphAI Therapeutics · NCT05798923 Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05844462

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.